Product information and disease descriptionPlace of product in therapyApproaches to treatmentCurrent treatment options and standard of care
Induction and maintenance immunosuppression
1 evidence topic · 1 source
Selected agents in the French imlifidase-enabled transplantation protocol
| Treatment role | Quoted agent |
|---|---|
| T-cell-depleting induction | “rATG” |
| Calcineurin inhibition | “tacrolimus” |
| Antimetabolite maintenance | “mycophenolic acid” |